OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 14, 2009
Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president and CEO; more...
May 07, 2009
Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for botulinum toxin producs; C. Richter King joins IAVI; more...
May 06, 2009
Best practices show the value of effective project management when outsourcing between a virtual pharmaceutical company and a contract manufacturing organization.
May 02, 2009
Strong growth in biopharmaceuticals bodes well for contract manufacturing, but the perils and the promises of pipelines remain.
A major CRO ventures further into proprietary drug development.
The president of BIO proposes the ingredients needed for industry growth.
The Japanese government is eager to jumpstart its generic-drug market, but changes must come first.
The GDP committee of IPEC–Europe is trying to seal one more broken link in the supply chain. This article contains bonus online-exclusive material.
Technology can solve enterprise-level problems.
May 01, 2009
The CRO market is experiencing two-tiered growth: firstly from pharmaceutical companies seeking to lower fixed costs by outsourcing clinical research to CROs; and secondly, from biotechnology and specialty pharmaceutical companies that lack the infrastructure to conduct trials.